These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 16325993

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapeutic use of the LNG IUS, and counseling.
    Pakarinen P, Toivonen J, Luukkainen T.
    Semin Reprod Med; 2001 Dec; 19(4):365-72. PubMed ID: 11727178
    [Abstract] [Full Text] [Related]

  • 3. Progestin-releasing intrauterine systems and leiomyoma.
    Kaunitz AM.
    Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R, Soneja H, Bhatia K, Ganesan R, Rollason T, Clark TJ, Gupta JK.
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [Abstract] [Full Text] [Related]

  • 6. Levonorgestrel-releasing intrauterine system: uses and controversies.
    Bahamondes L, Bahamondes MV, Monteiro I.
    Expert Rev Med Devices; 2008 Jul; 5(4):437-45. PubMed ID: 18573044
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The levonorgestrel intrauterine system: the benefits of reduced bleeding.
    Cameron IT.
    Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():27-32. PubMed ID: 11336431
    [Abstract] [Full Text] [Related]

  • 9. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F, Guillebaud J.
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Levonorgestrel releasing intrauterine spiral--contraception and therapeutic indications].
    Kunz J.
    Praxis (Bern 1994); 2001 Mar 15; 90(11):442-52. PubMed ID: 11293937
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S, Kelekci KH, Yilmaz B.
    Contraception; 2012 Nov 15; 86(5):458-63. PubMed ID: 22832203
    [Abstract] [Full Text] [Related]

  • 17. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET, Yigit R, Molenberghs G, Straetmans D, Ombelet W.
    Contraception; 2007 Aug 15; 76(2):91-5. PubMed ID: 17656176
    [Abstract] [Full Text] [Related]

  • 18. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S, Lang JH, Leng JH, Liu ZF, Sun DW, Zhu L.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 15; 41(10):664-8. PubMed ID: 17199919
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.